Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Target Acquired: Progress and Promise of Targeted Therapeutics in the Treatment of Prostate Cancer.

Current cancer drug targets - 1 Jan 2015

Stuchbery Ryan, Kurganovs Natalie J, McCoy Patrick J, Nelson Colleen C, Hayes Vanessa M, Corcoran Niall M, Hovens Christopher M

Abstract excerpt

Cancer is fundamentally a genomic disease caused by mutations or rearrangements in the DNA or epigenetic machinery of a patient. An emerging field in cancer treatment targets key aberrations arising from the mutational landscape of an individual patient's disease rather than employing a cancer-wide cytotoxic therapy approach. In prostate cancer in particular, where there is an observed variation in response to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents
Share to Drug Delivery Systems

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Gene Targeting

Share to Mutation

Share to Prostatic Neoplasms

Share to Treatment Outcome

Source

Identifiers

PMID: 25882061
DOI: 10.2174/1568009615666150416113453

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Target Acquired: Progress and Promise of Targeted Therapeutics in the Treatment of Prostate Cancer.PMID 25882061Read ↗

Molecular therapeutics in prostate cancer.Semantic proximity Read ↗

Germline and somatic mutations in prostate cancer: Implications for treatment.Semantic proximity Read ↗

Molecular landscape of prostate cancer: Implications for current clinical trialsSemantic proximity Read ↗

Molecular mechanisms and genetic alterations in prostate cancer: From diagnosis to targeted therapy.Semantic proximity Read ↗

Molecular heterogeneity in prostate cancer and the role of targeted therapySemantic proximity Read ↗

Precision Targets for Intercepting the Lethal Progression of Prostate Cancer: Potential Avenues for Personalized TherapySemantic proximity Read ↗

Therapeutic targeting of the DNA damage response in prostate cancerSemantic proximity Read ↗

Molecular Alterations in Prostate Cancer as Diagnostic, Prognostic, and Therapeutic TargetsSemantic proximity Read ↗

Treatment strategies for DNA repair-deficient prostate cancer.Semantic proximity Read ↗

Molecular pathology and prostate cancer therapeutics: from biology to bedside.Semantic proximity Read ↗

Androgen receptor mutations for precision medicine in prostate cancer.Semantic proximity Read ↗

Precision Targeting in Metastatic Prostate Cancer: Molecular Insights to Therapeutic FrontiersSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.